Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Neoplasms, Pleural

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Neoplasms, Pleural in 3 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mikami, I1
Zhang, F1
Hirata, T1
Okamoto, J1
Koizumi, K1
Shimizu, K1
Jablons, D1
He, B1
Miyoshi, S1
Hamada, H1
Hamaguchi, N1
Kato, A1
Katayama, H1
Irifune, K1
Ito, R1
Miyazaki, T1
Okura, T1
Higaki, J1
Mukohara, T1
Civiello, G1
Johnson, BE1
Janne, PA1

Other Studies

3 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Neoplasms, Pleural

ArticleYear
Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest.
    Oncology reports, 2010, Volume: 24, Issue:6

    Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromones; Down-Regulation; Drug Evaluation, Precl

2010
Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo.
    International journal of oncology, 2012, Volume: 41, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Butadienes; Cell Proliferation; Chromones; Drug Synergism

2012
Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma.
    Oncology, 2005, Volume: 68, Issue:4-6

    Topics: Antibiotics, Antineoplastic; Butadienes; Cell Cycle; Chromones; Enzyme Inhibitors; ErbB Receptors; G

2005